Send to a Friend Font Size: Increase Decrease

GMAB and ABBV Related Headlines

Jul 23, 2026 04:00PM Genmab and AbbVie say epcoritamab trial missed U.S. survival goal
Jul 23, 2026 04:00PM Genmab and AbbVie Provide Clarification on Phase 3 EPCORE® DLBCL-1 Trial Evaluating Epcoritamab (DuoBody®-CD3xCD20) in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)

GMAB and ABBV Related Press Releases

Jul 23, 2026 04:00PM Genmab and AbbVie Provide Clarification on Phase 3 EPCORE® DLBCL-1 Trial Evaluating Epcoritamab (DuoBody®-CD3xCD20) in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)

GMAB and ABBV Related SEC Filings